BioCentury | Sep 5, 2019
Company News

Management tracks: Locana, Synlogic, Farcast, Oncology Venture, Cala, Novaremed, Sidley Austin and Logos Capital

...chairs its SAB. Bishop was CSO at Otonomy Inc. (NASDAQ:OTIC) and previously held roles at Tioga Pharmaceuticals Inc....
BioCentury | Jan 17, 2018
Distillery Techniques

Drug platforms

...CR845, a KOR agonist, in Phase III and Phase II testing, respectively, to treat pain. Tioga Pharmaceuticals Inc....
BioCentury | Jan 3, 2017
Distillery Therapeutics

Neurology; dermatology

...steps could include testing the biased KOR agonist in additional models of pain and itch. Tioga Pharmaceuticals Inc....
BioCentury | Aug 11, 2016
Distillery Therapeutics

Therapeutics: κ opioid receptor (KOR; OPRK1)

...compared with vehicle. Next steps could include testing KOR agonists in additional models of MS. Tioga Pharmaceuticals Inc....
BioCentury | Jun 22, 2015
Clinical News

Asimadoline: Phase II started

...evaluate 5 mg oral asimadoline daily for up to 8 weeks in about 200 patients. Tioga Pharmaceuticals Inc....
BioCentury | Apr 14, 2014
Company News

MEI Pharma management update

...Urso as SVP of corporate development and general counsel, formerly COO and general counsel at Tioga Pharmaceuticals Inc. WIR...
BioCentury | Feb 10, 2014
Product Development

Furiex's run at IBS-D

...is being developed for chronic use, so it does not require retreatment data. Behind Xifaxan, Tioga Pharmaceuticals Inc....
...Amsterdam, the Netherlands PPD LLC , Wilmington, N.C. Salix Pharmaceuticals Inc. (NASDAQ:SLXP), Raleigh, N.C. Tioga Pharmaceuticals Inc....
BioCentury | Mar 18, 2013
Emerging Company Profile

gIcare: Colonoscopy comfort

...opioid receptor agonists for pain associated with GI indications, though not for use during colonoscopy. Tioga Pharmaceuticals Inc....
...Morrisville, N.C. gIcare pharma Inc. , Montreal, Quebec Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Tioga Pharmaceuticals Inc....
BioCentury | Jan 7, 2013
Finance

Buyside View XXI: Sunny side up

Stephen Hansen Senior Writer A strong crop of early PDUFA dates and a sense that FDA is more navigable have given money managers in the U.S. and Europe a positive outlook for 2013, which they...
BioCentury | Dec 24, 2012
Emerging Company Profile

Aros: Easing IBS pain

...opioid receptor delta 1 ( OPRD1 ; DOR) antagonist that is in Phase III testing. Tioga Pharmaceuticals Inc....
...Ono Pharmaceutical Co. Ltd. (Tokyo:4528; Osaka: 4528), Osaka, Japan Theralpha S.A.S. , Sophia Antipolis, France Tioga Pharmaceuticals Inc....
Items per page:
1 - 10 of 33
BioCentury | Sep 5, 2019
Company News

Management tracks: Locana, Synlogic, Farcast, Oncology Venture, Cala, Novaremed, Sidley Austin and Logos Capital

...chairs its SAB. Bishop was CSO at Otonomy Inc. (NASDAQ:OTIC) and previously held roles at Tioga Pharmaceuticals Inc....
BioCentury | Jan 17, 2018
Distillery Techniques

Drug platforms

...CR845, a KOR agonist, in Phase III and Phase II testing, respectively, to treat pain. Tioga Pharmaceuticals Inc....
BioCentury | Jan 3, 2017
Distillery Therapeutics

Neurology; dermatology

...steps could include testing the biased KOR agonist in additional models of pain and itch. Tioga Pharmaceuticals Inc....
BioCentury | Aug 11, 2016
Distillery Therapeutics

Therapeutics: κ opioid receptor (KOR; OPRK1)

...compared with vehicle. Next steps could include testing KOR agonists in additional models of MS. Tioga Pharmaceuticals Inc....
BioCentury | Jun 22, 2015
Clinical News

Asimadoline: Phase II started

...evaluate 5 mg oral asimadoline daily for up to 8 weeks in about 200 patients. Tioga Pharmaceuticals Inc....
BioCentury | Apr 14, 2014
Company News

MEI Pharma management update

...Urso as SVP of corporate development and general counsel, formerly COO and general counsel at Tioga Pharmaceuticals Inc. WIR...
BioCentury | Feb 10, 2014
Product Development

Furiex's run at IBS-D

...is being developed for chronic use, so it does not require retreatment data. Behind Xifaxan, Tioga Pharmaceuticals Inc....
...Amsterdam, the Netherlands PPD LLC , Wilmington, N.C. Salix Pharmaceuticals Inc. (NASDAQ:SLXP), Raleigh, N.C. Tioga Pharmaceuticals Inc....
BioCentury | Mar 18, 2013
Emerging Company Profile

gIcare: Colonoscopy comfort

...opioid receptor agonists for pain associated with GI indications, though not for use during colonoscopy. Tioga Pharmaceuticals Inc....
...Morrisville, N.C. gIcare pharma Inc. , Montreal, Quebec Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Tioga Pharmaceuticals Inc....
BioCentury | Jan 7, 2013
Finance

Buyside View XXI: Sunny side up

Stephen Hansen Senior Writer A strong crop of early PDUFA dates and a sense that FDA is more navigable have given money managers in the U.S. and Europe a positive outlook for 2013, which they...
BioCentury | Dec 24, 2012
Emerging Company Profile

Aros: Easing IBS pain

...opioid receptor delta 1 ( OPRD1 ; DOR) antagonist that is in Phase III testing. Tioga Pharmaceuticals Inc....
...Ono Pharmaceutical Co. Ltd. (Tokyo:4528; Osaka: 4528), Osaka, Japan Theralpha S.A.S. , Sophia Antipolis, France Tioga Pharmaceuticals Inc....
Items per page:
1 - 10 of 33